Ad
BBLG - Bone Biologics Corp Stock Trading
About | Bone Biologics Corp (OTCMKTS:BBLG)
Bone Biologics was founded to pursue regenerative medicine for bone. Bone Biologics is currently focusing its development efforts of its bone graft substitute product on bone regeneration in spinal fusion. Our proprietary platform technology, NELL , is a recombinant human protein growth factor that is essential for normal bone development.
Quote | Bone Biologics Corp (OTCMKTS:BBLG)
| Last: | $7.5001 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $7.5001 |
| Close: | $7.5001 |
| High: | $7.5001 |
| Low: | $7.5001 |
| Volume: | 150 |
| Last Trade Date Time: | 03/19/2021 04:42:06 am |
News | Bone Biologics Corp (OTCMKTS:BBLG)
-
Bone Biologics Corporation (NASDAQ: BBLG) , a developer of orthobiologic products for spine fusion markets, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of an aggregate of 1,139,063 of its shares of common stock at a ...
-
2023-11-17 09:39:20 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Li Auto (NASDAQ: LI ) stock fans will want to mark their calendars for Dec. 4 as a major catalyst for the electric vehicle (EV) company’s shares will take place on that d...
Message Board Posts | Bone Biologics Corp (OTCMKTS:BBLG)
| Subject | By | Source | When |
|---|---|---|---|
| Only a few trades a year look this | 81vette | investorshub | 04/04/2023 3:26:53 PM |
| 9X relative vol,buckle up on this babe | 81vette | investorshub | 04/04/2023 2:29:23 PM |
| $BBLG: Trying to bounce higher at 0.24 | makinezmoney | investorshub | 12/27/2022 4:24:50 PM |
| How is Wallacebeth Capitals track record on its IPOs? | IPO$ | investorshub | 12/15/2022 5:34:11 PM |
| Revenues chit the bed ! <> $0.00 | crudeoil24 | investorshub | 11/16/2022 1:05:37 PM |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
Bone Biologics Corp (NASDAQ: BBLG) shares are trading lower by 12% to $0.54 Monday morning on downward momentum after the company last we...
-
Bone Biologics Corporation (NASDAQ: BBLG) , a developer of orthobiologic products for spine fusion markets, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of an aggregate of 1,139,063 of its shares of common stock at a ...
-
U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 30 points on Friday. The Dow trade...